데이터 상품 상세검색

[감염병특허]

감염병이 등장한 특허문서내 문장정보 (미국특허)

감염병이 등장한 특허문서내 문장정보

  • 등록일2022-12-08
  • 조회수1349
  • 다운로드217
  • 카테고리감염병특허
  • 6

데이터 기본 이용료

  • 200,000원
상세정보
데이터등록일 데이터 수정일 데이터 이용기한 판매제공처
2022-12-08 2023-07-25 무기한 BLT
데이터 제공포맷 데이터 제공방식 데이터 파일용량 데이터 상품구분
csv/zip 다운로드 33.09 GB dataset

■ 데이터상품설명 ICD 질병분류코드에 정의된 감염질환을 기준으로 질병별로 정리된 특허데이터를 가공해 제공합니다. 본 데이터 상품은 특허 데이터를 문장단위로 가공하여 특정 감염질환이 등장한 문장만을 선별 제공하는 것을 목적으로 하고 있으며, 질병/특허번호/날짜/권리자/문장구역/문장정보 등의 정보가 수록되어있습니다. ■ 간략 통계 수록 감염병: 약 600종 (정의된 감염질환 1200여개에 대해 모두 스크리닝) 수록 특허수: 약 4만건 (2023년 02월 현재기준) 질병당 특허수 :평균 222건 (최소1 최대 6977건) 질병당 문장수: 평균 18,303개 ※ xml파일이 제공되지 않는 특허는 제목만 수록되어 있습니다. ■ 데이터 내용설명 아래와 같은 데이터를 포함하고 있습니다 1) 질병정보 (질병ID/질병코드/질병명) 2) 특허번호정보 (특허ID/출원번호/등록번호) 3) 특허날짜정보 (출원일자/등록일자) 4) 특허권리자 5) 특허문장 (구역구분/문단ID/문장ID/문장정보) ■ 참고: ICD10 질병분류코드 코로나바이러스감염증-19 [U07.1] 콜레라 [A00] 결핵 [A15-A19] 디프테리아 [A36] 패혈증 [A40-41] 크로이츠펠트-야콥병 [A81.0] 바이러스수막염 [A87] 지카 바이러스 질환 [A92.5] 황열 [A95] 뎅기 [A97] 에볼라바이러스병 [A98.4] 헤르페스바이러스[단순헤르페스] 감염 [B00] 대상포진 [B02] 바이러스간염 [B15-B19] 인체면역결핍바이러스병 [B20-B24] 감염성 단핵구증 [B27] 백선증 [B35] 칸디다증 [B37] 샤가스병 [B57] 연충증 [B65-B83] 메티실린 내성 황색포도상구균 [U82.1]

샘플정보
컨텐츠ID
컨텐츠영어명
컨텐츠한국어명
컨텐츠대분류명
질병분류코드
MESH분류코드
국가코드
특허ID
특허출원번호
특허공개번호
특허등록번호
특허출원일자
특허출원공개일자
특허등록일자
특허최초공보발행일자
현재특허권리자그룹
특허발명의명칭제목
문장구역구분
문단ID
문장ID
문장데이터
메인CPC특허분류코드
전체CPC특허분류코드목록
CPC특허분류코드개수
메인IPC특허분류코드
전체IPC특허분류코드목록
IPC특허분류코드개수
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20090226417A1 11/890871 20090226417 20070808 20090910 20090910 Immunex Human B7 polypeptides claim CLM-00003 s-00001 (a) SEQ ID NO:4; C07K14/70532 C07K14/70532|A61K39/00|A61K38/00 3 A61K39/395 A61K39/395|C12P21/04|C12N5/06|C12N15/11|C12N15/00|C07K16/18|A61K39/00|A61K38/16 8
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20090275583A1 12/422767 20090275583 20090413 20091105 20091105 Myrexis ANTIVIRAL COMPOUNDS AND USE THEREOF claim CLM-00017 s-00006 (2) hydroxyl; cyano; C07J63/008 C07J63/008|A61P31/18 2 A61K31/5375 A61K31/5375|A61P31/18|C07D265/30 3
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20090275583A1 12/422767 20090275583 20090413 20091105 20091105 Myrexis ANTIVIRAL COMPOUNDS AND USE THEREOF claim CLM-00001 s-00023 (3) O-carboxy; C07J63/008 C07J63/008|A61P31/18 2 A61K31/5375 A61K31/5375|A61P31/18|C07D265/30 3
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20090312335A1 12/084158 20090312335 20061023 20091217 20091217 MSD (Merck & Company) Hiv Integrase Inhibitors claim CLM-00001 s-00050 (12) ?C2-5 alkynyl-CH2ORa, C07D487/04 C07D487/04|A61P43/00|A61P31/18 3 A61K31/495 A61K31/495|C07D471/04 2
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20090312335A1 12/084158 20090312335 20061023 20091217 20091217 MSD (Merck & Company) Hiv Integrase Inhibitors claim CLM-00001 s-00051 (13) ?C2-5 alkynyl-CH2S(O)nRc, or C07D487/04 C07D487/04|A61P43/00|A61P31/18 3 A61K31/495 A61K31/495|C07D471/04 2
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20100120786A1 12/603380 20100120786 20091021 20100513 20100513 Concert Pharmaceuticals Piperazine Derivatives claim CLM-00008 s-00000 The compound of claim 6, wherein R2 and R3 are deuterium. C07D401/14 C07D401/14|A61P31/18|A61P31/12 3 A61K31/497 A61K31/497|A61P31/12|A61P31/18|C07D403/14 4
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20100137283A1 12/697513 20100137283 20100201 20100603 20100603 Pfizer INHIBITORS OF THE HIV INTEGRASE ENZYME claim CLM-00001 s-00009 R6 is hydrogen; C07D491/14 C07D491/14|A61P31/18|C07D471/14|A61P43/00 4 A61K31/55 A61K31/55|A61K31/5377|C12N9/99|A61K31/551|C07D471/14|A61K31/437 6
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20110257111A1 13/125464 20110257111 20091023 20111020 20111020 Concert Pharmaceuticals Hydroxyethlamino Sulfonamide Derivatives claim CLM-00014 s-00163 CH2CH(CH3)2 C07D493/04 C07D493/04|A61P31/18|A61P33/06 3 A61K31/7028 A61K31/7028|C07F9/6561|A61K31/675|A61K31/635|A61P33/06|C07D493/04|A61P31/18 7
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20110257111A1 13/125464 20110257111 20091023 20111020 20111020 Concert Pharmaceuticals Hydroxyethlamino Sulfonamide Derivatives claim CLM-00014 s-00164 H C07D493/04 C07D493/04|A61P31/18|A61P33/06 3 A61K31/7028 A61K31/7028|C07F9/6561|A61K31/675|A61K31/635|A61P33/06|C07D493/04|A61P31/18 7
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20110257111A1 13/125464 20110257111 20091023 20111020 20111020 Concert Pharmaceuticals Hydroxyethlamino Sulfonamide Derivatives claim CLM-00014 s-00188 D C07D493/04 C07D493/04|A61P31/18|A61P33/06 3 A61K31/7028 A61K31/7028|C07F9/6561|A61K31/675|A61K31/635|A61P33/06|C07D493/04|A61P31/18 7
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20110257111A1 13/125464 20110257111 20091023 20111020 20111020 Concert Pharmaceuticals Hydroxyethlamino Sulfonamide Derivatives claim CLM-00014 s-00381 H C07D493/04 C07D493/04|A61P31/18|A61P33/06 3 A61K31/7028 A61K31/7028|C07F9/6561|A61K31/675|A61K31/635|A61P33/06|C07D493/04|A61P31/18 7
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20100216834A1 12/445594 20100216834 20071015 20100826 20100826 Fisher, Thorsten E|Isaacs, Richard C.A.|Payne, Linda S|Wai, John S HIV INTEGRASE INHIBITORS claim CLM-00001 s-00002 R5a is H or OH; C07D471/14 C07D471/14|A61P43/00|A61P31/18 3 A61K31/4375 A61K31/4375|A61P31/18|C07D471/04|C07D471/14 4
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20100275346A1 12/294887 20100275346 20061213 20101104 20101104 Delonas Terry Lipowear claim CLM-00017 s-00000 A method of providing improved sitting comfort to a person, comprising: A41B9/001 A41B9/001|A41D13/1254|A41D13/0537 3 A41B9/00 A41B9/00|A41D27/00 2
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20140018379A1 13/579528 20140018379 20110218 20140116 20140116 Concert Pharmaceuticals PYRIMIDINE DERIVATIVES claim CLM-00007 s-00136 117 C07D239/48 C07D239/48|C07B59/002|A61P31/18 3 C07D239/48 C07D239/48 1
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20140018379A1 13/579528 20140018379 20110218 20140116 20140116 Concert Pharmaceuticals PYRIMIDINE DERIVATIVES claim CLM-00007 s-00139 H C07D239/48 C07D239/48|C07B59/002|A61P31/18 3 C07D239/48 C07D239/48 1
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20140018379A1 13/579528 20140018379 20110218 20140116 20140116 Concert Pharmaceuticals PYRIMIDINE DERIVATIVES claim CLM-00011 s-00108 H C07D239/48 C07D239/48|C07B59/002|A61P31/18 3 C07D239/48 C07D239/48 1
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20130029945A1 13/519817 20130029945 20101006 20130131 20130131 Cipla Darunavir Polymorph and Process for Preparation Thereof claim CLM-00004 s-00006 34 C07D493/04 C07D493/04|A61P43/00|A61P31/18 3 C07D493/04 C07D493/04|A61P31/18|A61K31/635 3
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20140018379A1 13/579528 20140018379 20110218 20140116 20140116 Concert Pharmaceuticals PYRIMIDINE DERIVATIVES claim CLM-00008 s-00063 D C07D239/48 C07D239/48|C07B59/002|A61P31/18 3 C07D239/48 C07D239/48 1
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20140018379A1 13/579528 20140018379 20110218 20140116 20140116 Concert Pharmaceuticals PYRIMIDINE DERIVATIVES claim CLM-00008 s-00064 D C07D239/48 C07D239/48|C07B59/002|A61P31/18 3 C07D239/48 C07D239/48 1
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20140018379A1 13/579528 20140018379 20110218 20140116 20140116 Concert Pharmaceuticals PYRIMIDINE DERIVATIVES claim CLM-00011 s-00115 D C07D239/48 C07D239/48|C07B59/002|A61P31/18 3 C07D239/48 C07D239/48 1
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20130029945A1 13/519817 20130029945 20101006 20130131 20130131 Cipla Darunavir Polymorph and Process for Preparation Thereof claim CLM-00004 s-00022 23 C07D493/04 C07D493/04|A61P43/00|A61P31/18 3 C07D493/04 C07D493/04|A61P31/18|A61K31/635 3
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20140018379A1 13/579528 20140018379 20110218 20140116 20140116 Concert Pharmaceuticals PYRIMIDINE DERIVATIVES claim CLM-00008 s-00072 D C07D239/48 C07D239/48|C07B59/002|A61P31/18 3 C07D239/48 C07D239/48 1
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20140018379A1 13/579528 20140018379 20110218 20140116 20140116 Concert Pharmaceuticals PYRIMIDINE DERIVATIVES claim CLM-00008 s-00071 H C07D239/48 C07D239/48|C07B59/002|A61P31/18 3 C07D239/48 C07D239/48 1
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20120022018A1 13/187222 20120022018 20110720 20120126 20120126 Bespoke Bioscience ANTI-VIRAL PROPERTIES OF ALOE VERA AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) TREATMENT claim CLM-00041 s-00141 mg A61K31/715 A61K31/715|A61K31/135|A61P37/00|A23L33/40|A61P31/18|A23L33/30|A23V2200/00|A61K36/886|A23V2002/00|A61K31/736|A61P43/00 11 A61K31/715 A61K31/715|A61P31/18|A61K31/736|A61P37/00 4
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20130164278A1 13/568896 20130164278 20120807 20130627 20130627 Ac Immune|Genentech HUMANIZED ANTIBODY claim CLM-00048 s-00000 (canceled) A61P25/00 A61P25/00|C07K16/28|G01N33/6896|C07K2317/56|C07K16/18|C07K2317/34|A61P25/28|C07K2317/24|A61P25/16|A61K2039/505|C07K2317/565 11 C07K16/28 C07K16/28 1
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20120220571A1 13/392169 20120220571 20100816 20120830 20120830 Su, Dai-Shi|Wai, John S|Wiscount, Catherine, M. HIV INTEGRASE INHIBITORS claim CLM-00011 s-00031 (20) HetD, C07D491/052 C07D491/052|A61P31/18|C07D471/14|C07D471/04|A61P37/00 5 A61K31/436 A61K31/436|A61K31/4375|A61K31/55|A61P31/18|A61P37/00|C07D471/04|C07D487/14|C07D491/052 8
211726 Human immunodeficiency virus [HIV] disease 인체면역결핍바이러스병 인체면역결핍바이러스병 B20-B24 US US20120052088A1 13/266846 20120052088 20100317 20120301 20120301 Coley Pharmaceutical Group PNEUMOCOCCAL VACCINE AND USES THEREOF claim CLM-00085 s-00000 The pneumococcal vaccine of claim 83, wherein the additional adjuvant is alum, aluminium hydroxide, aluminum phosphate, or aluminum sulphate. A61K39/092 A61K39/092|A61K2039/55561|A61P9/04|A61P31/18|A61P1/16|A61P13/12|A61P43/00|A61P9/00|A61P31/12|A61P1/00|A61P11/08|A61P37/04|A61P7/00|A61P31/04|A61K39/385|A61P11/06|A61P35/02|A61P3/10|A61P25/32|A61K2039/6037|A61P11/00|A61P35/00|A61P3/00|A61P25/00 24 A61K39/385 A61K39/385|A61P9/04|A61P9/00|A61P7/00|A61P35/02|A61P35/00|A61P31/12|A61P31/18|A61P31/04|A61P3/10|A61K39/09|A61P1/00|A61P1/16|A61P11/00|A61P11/06|A61P11/08|A61P13/12|A61P25/00|A61P25/32|A61P3/00 20
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00075 wherein alkyl and aryl are optionally substituted with one to three substituents selected from a group independently selected from Rc; C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00076 each Rc is independently selected from: C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00077 (1) halogen, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00078 (2) amino, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00079 (3) carboxy, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00080 (4) C1-4alkyl, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00081 (5) C1-4alkoxy, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00083 (7) aryl C1-4alkyl, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00084 (8) hydroxy, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00085 (9) CF3, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00086 (10) ?OC(O)C1-4alkyl, and C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00087 (11) ?OC(O)NRdRe; C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00088 Rd is selected from: C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00089 (1) hydrogen, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211679 Typhus fever 발진티푸스 리케차병 A75 US US00008084247B2 12/658214 20100151563 8084247 20100204 20100617 20111227 20100617 American Sterilizer Biological indicator title t-0000 s-00000 Biological indicator G01N33/54353 G01N33/54353|C12Q1/22 2 C12M1/34 C12M1/34 1
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00090 (2) C1-10alkyl, unsubstituted or substituted with one to three substituents selected from Rh, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00091 (3) C2-4alkenyl; C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00092 (4) cycloalkyl, unsubstituted or substituted with one to three substituents selected from Rh; C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00093 (5) cycloalkyl-C1-4alkyl; C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00094 (6) cycloheteroalkyl, unsubstituted or substituted with one to three substituents selected from Rh; C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007303907B2 10/614370 20040091474 7303907 20030708 20040513 20071204 20040513 Health Protection Agency Degradation and detection of TSE infectivity claim CLM-00006 s-00000 The method of claim 1, wherein the TSE agent is a prion dimer. C11D3/48 C11D3/48|C07K16/18|A61L2/22|G01N2800/2828|C07K16/2872|C07K14/47|A61L2/18|C12N9/52|C12N9/54|C11D3/38618 10 C02F3/34 C02F3/34|D06M16/00|C11D3/386|C07K14/47|A61L2/22|C12N9/52|C07K16/18|C07K16/28|C11D3/48|C12N9/54|A61L2/18 11
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007326692B2 09/993363 20030148511 7326692 20011114 20030807 20080205 20030807 University of Chicago Induction of immunity using inhibitors of granzymes claim CLM-00023 s-00000 The method of claim 1, wherein the serpin or serpin mimetic inhibits granzyme function. C12N5/0636 C12N5/0636|C12N2510/00|Y02A50/30|A61K35/17|A61K31/70|A61K38/57|A61K47/6849 7 A61K48/00 A61K48/00|C12N15/74|C12N15/63|A61K47/48|A61K38/55|C12N5/0783|A61K31/70|A61K35/12 8
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00095 (7) cycloheteroalkyl-C1-4alkyl, unsubstituted or substituted with a Rh substituent; C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00096 (8) aryl, unsubstituted or substituted with one to three substituents selected from Rh; C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00097 (9) heteroaryl, unsubstituted or substituted with one to three substituents selected from Rh; C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00098 (10) aryl-C1-4alkyl, unsubstituted or substituted with one to three substituents selected from Rh; and C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00099 (11) heteroaryl-C1-4alkyl, unsubstituted or substituted with one to three substituents selected from Rh; C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00100 Re is hydrogen, or C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007311893B2 10/728028 20050048000 7311893 20031203 20050303 20071225 20050303 Bellus Health (International) Amyloid targeting imaging agents and uses thereof claim CLM-00001 s-00003 and pharmaceutically acceptable salts thereof; A61K51/088 A61K51/088|A61K51/0497 2 A61K51/00 A61K51/00|A61K51/04|A61K51/08 3
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007326692B2 09/993363 20030148511 7326692 20011114 20030807 20080205 20030807 University of Chicago Induction of immunity using inhibitors of granzymes claim CLM-00024 s-00000 The method of claim 1, wherein the serpin or serpin mimetic is a serpin. C12N5/0636 C12N5/0636|C12N2510/00|Y02A50/30|A61K35/17|A61K31/70|A61K38/57|A61K47/6849 7 A61K48/00 A61K48/00|C12N15/74|C12N15/63|A61K47/48|A61K38/55|C12N5/0783|A61K31/70|A61K35/12 8
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00101 Rd and Re together with the atom(s) to which they are attached form a heterocyclic ring of 4 to 7 members containing 0 or 1 additional heteroatoms independently selected from oxygen, sulfur and N?Rh, unsubstituted or substituted with one or two oxo groups; C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00102 Rf and Rg are independently selected from C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007279168B2 09/303040 20020051792 7279168 19990430 20020502 20071009 20020502 Intervet International Recombinant virus expressing foreign DNA encoding feline CD86 and uses thereof claim CLM-00009 s-00000 The recombinant virus of claim 8, wherein the pathogen is a feline pathogen, a rabies virus, Chlamydia, Toxoplasma gondii, Dirofilaria immitis, a flea, or a bacterial pathogen. A61K39/275 A61K39/275|A61P43/00|A61K2039/5256|A61K38/1774|A61K38/208|A61K39/00|A61K39/39|A61P35/00|A61K2039/55516 9 A61K39/00 A61K39/00|A61K39/21|A61K39/205|A61K39/12|A61K39/02|A61K38/17|A61K39/39 7
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00103 (1) hydrogen, and C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00104 (2) methyl; C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00105 each Rh is independently selected from: C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00106 (1) halogen, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00107 (2) amino, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00108 (3) hydroxycarbonyl, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00109 (4) C1-4alkyl, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00110 (5) C1-4alkoxy, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00111 (6) aryl, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00112 (7) aryl C1-4alkyl, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00113 (8) hydroxy, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00114 (9) trifluoromethyl, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00115 (10) ?OC(O)C1-4alkyl, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00116 (11) aryloxy-, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00117 (12) C1-4alkyloxycarbonyl-, and C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00118 (13) ?C(O)?NH?C1-4alkyl; C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00119 m is selected from 1 and 2; C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00120 n is selected from 1, 2, and 3; C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00121 p is selected from 0, 1, and 2; and C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00006 s-00122 and pharmaceutically acceptable salts thereof. C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00007 s-00000 The compound according to claim 6, wherein: C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00007 s-00001 R1 is selected from: C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00007 s-00002 (1) hydrogen, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00007 s-00003 (2) chloro, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00007 s-00004 (3) cycloheteroalkyl, selected from piperidyl, piperazinyl, and perhydroazepine, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00007 s-00005 (4) heteroaryl, selected from imidazole, triazole, benzimidazole, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00007 s-00006 (5) benzyl, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00007 s-00007 (6) ?Ord, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00007 s-00008 (7) ?SRd, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00007 s-00009 (8) ?O?(CH2)2?NrdRe, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00007 s-00010 (9) ?O?(CH2)2?NH?C(O)?Rd, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00007 s-00011 (10) ?O?(CH2)2?NH?S(O)pRd, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00007 s-00012 (12) ?O?(CH2)n?C(O)?NrdRe, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00007 s-00013 (13) ?NrdRe, wherein Re is hydrogen, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00007 s-00014 (14) ?CO2H, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00007 s-00015 (15) ?C(O)NrdRe, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00007 s-00016 wherein the cycloheteroalkyl, aryl and heteroaryl are optionally substituted with one to three substituents independently selected from Rb; C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00007 s-00017 R2 is selected from: C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007276516B2 10/596495 20070088018 7276516 20041213 20070419 20071002 20070419 Eli Lilly and Company CB1 antagonist compounds claim CLM-00002 s-00031 R10 is hydrogen or alkyl; C07D209/10 C07D209/10|C07D209/08|C07D209/14|A61P3/04|C07D209/96|C07D401/04|C07D209/12|C07D209/40|C07D471/04|C07D491/10|C07D209/42|C07D231/56|A61P25/06|A61P25/16|C07D471/10|A61P25/24|A61P43/00|A61P25/08|A61P25/18|C07D401/12|C07D403/12|A61P25/22|A61P25/28|C07D405/12|C07D417/04|C07D403/04|C07D405/04|A61P1/14|A61P25/00|C07D405/06|C07D409/04 31 A01N43/42 A01N43/42|C07D491/02|C07D471/02|A61K31/541|A61K31/5377|A61K31/501|A61K31/497|A61K31/496|A61K31/44|A01N43/38|C07D209/42|C07D231/56|C07D409/04|C07D209/96|C07D209/12|C07D209/14|C07D491/10|C07D401/04|C07D209/10|C07D401/12|C07D471/04|C07D209/40|C07D417/04|C07D471/10|C07D405/12|C07D403/04|C07D209/08|C07D405/06|C07D403/12|C07D405/04 30
211682 Viral infections of the central nervous system 중추신경계통의 바이러스감염 중추신경계통의 바이러스감염 A80-A89 US US00007271266B2 10/508043 20050182103 7271266 20030324 20050818 20070918 20050818 MSD (Merck & Company) Substituted 2,3-diphenyl pyridines claim CLM-00007 s-00018 (1) hydrogen, C07D213/79 C07D213/79|A61P9/00|C07D213/86|A61P11/06|A61P25/06|C07D213/65|A61P25/08|C07D213/80|C07D213/82|A61P25/22|C07D213/85|C07D213/87|A61P29/00|C07D401/12|A61P25/16|A61P1/04|A61P25/18|A61P25/28|A61P3/04|A61P25/30|A61P43/00|A61P25/00|C04B35/632|A61P1/10|C07D213/81|A61P1/16 26 C07D211/82 C07D211/82|C07D211/60|C07D213/86|A61P25/16|A61P3/04|A61K31/496|A61K47/34|A61P11/06|A61P25/06|C07D213/82|A61P1/16|A61P25/18|A61P25/28|A61K31/4439|A61P29/00|C07D213/87|A61K31/44|A61K45/00|A61K31/4545|C07D213/85|A61P25/30|A61P25/22|A61P43/00|C07D401/12|C07D213/56|A61K47/02|A61P25/00|C07D213/80|C07D213/64|A61K31/5377|A61P1/10|C07D213/65|C07D213/81|A61K47/26|A61P1/04|A61P25/08|A61K31/4418|A61K47/10|A61K31/455|C07D213/79|A61P9/00 41
상품 미리보기
연락처 및 데이터 관리
판매제공처 홈페이지 판매담당자 연락처 이메일
 www.BLT.kr 특허법인BLT 02-514-0104  khpark@blt.kr
제약 및 취소환불 규정
제약 및 취소/환불 규정 안내
데이터 상품은 디지털화된 상품의 특성상 반품, 취소, 환불 되지 않으나 데이터의 심각한 오류, 상이한 데이터에 한하여 구매자가 요구하는 경우 환불을 진행할 수 있습니다.
상품 Q&A

※ 본인의 글만 수정이 가능하며, 타인의 글에 댓글을 남길 수 없습니다.
※ 댓글이 달린 글은 수정과 삭제가 불가능합니다.

등록된 글이 없습니다.

닫기버튼
해당 문의 내역을 삭제하시겠습니까?

닫기버튼
해당 문의 내역을 삭제하시겠습니까?